An anti-abortion group challenged the FDA's approval of one of the drugs used for medication abortions, and access could be affected pending a federal judge's ruling after a hearing in Texas. Sarah McCammon, national correspondent for NPR, reports on the hearing and what's at stake for reproductive rights.